Tocilizumab reduces mechanical ventilation in severe COVID-19 patients

The investigators found in a review article of 8 RCTs with 6,311 COVID-19 patients and 28 cohort studies with 15,484 COVID-19 patients, that cumulative high certainty evidence shows that tocilizumab reduces the risk of mechanical ventilation in hospitalized patients with severe COVID-19. Moderate certainty evidence shows that tocilizumab reduces the risk of poor outcome and the risk of secondary infections in hospitalized COVID-19 patients.

Read more right here:
Tocilizumab reduces mechanical ventilation in severe COVID-19 patients